A Cancer Diagnosis Is Not The End Of The World – Read These Helpful Tips (4)

A Cancer Diagnosis Is Not The End Of The World – Read These Helpful Tips Most of us thrive on routine and a sense of normality in our lives. This…
Read more
Simple Ways To Manage Cancer (3)

Simple Ways To Manage Cancer There are millions of cases of cancer diagnosed around the world every year. Some are severe and others are definitely curable, but they will all…
Read more
Cancer: Advice On Learning How To Cope (2)

Cancer: Advice On Learning How To Cope If you or a loved one has been diagnosed with cancer, it can be a very scary time. There are so many questions…
Read more
What To Look For When Choosing An Oncologist (2)

What To Look For When Choosing An Oncologist Many of us never actually stop to smell the proverbial roses until we find out that we don’t have a lot of…
Read more
Tips On How To Steer Away From Cancer (5)

Tips On How To Steer Away From Cancer Being able to have a friendly and informative back-and-forth conversation with your doctor is crucial if you want to know your treatment…
Read more

Posts tagged as “VBLT”

Vascular Biogenics’ (VBLT) CEO Dror Harats on Q2 2019 Results – Earnings Call Transcript – Seeking Alpha

Published 14th August 2019 by admin

Vascular Biogenics’ (VBLT) CEO Dror Harats on Q2 2019 Results – Earnings Call Transcript – Seeking Alpha

Vascular Biogenics’ (VBLT) CEO Dror Harats on Q2 2019 Results – Earnings Call Transcript Seeking Alpha Vascular Biogenics Ltd. (NASDAQ:VBLT) Q2 2019 Earnings Conference Call August 13, 2019 8:30 AM ET…

VBL (VBLT) Final Phase 1/2 Study Results Presented at ASCO Demonstrate VB-111 Dose Dependent Increase in OS and 58% CA-125 Response Rate in Platinum-Resistant Ovarian Cancer – StreetInsider.com

Published 9th June 2019 by admin

VBL (VBLT) Final Phase 1/2 Study Results Presented at ASCO Demonstrate VB-111 Dose Dependent Increase in OS and 58% CA-125 Response Rate in Platinum-Resistant Ovarian Cancer – StreetInsider.com

VBL (VBLT) Final Phase 1/2 Study Results Presented at ASCO Demonstrate VB-111 Dose Dependent Increase in OS and 58% CA-125 Response Rate in Platinum-Resistant Ovarian Cancer StreetInsider.com VBL Therapeutics (Nasdaq: VBLT)…

Edited Transcript of VBLT earnings conference call or presentation 15-May-19 12:30pm GMT – Yahoo Finance

Published 19th May 2019 by admin

Edited Transcript of VBLT earnings conference call or presentation 15-May-19 12:30pm GMT – Yahoo Finance

Edited Transcript of VBLT earnings conference call or presentation 15-May-19 12:30pm GMT Yahoo Finance Q1 2019 Vascular Biogenics Ltd Earnings Call. OR YEHUDA May 16, 2019 (Thomson StreetEvents) — Edited Transcript…

Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q1 2019 Results – Earnings Call Transcript – Seeking Alpha

Published 16th May 2019 by admin

Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q1 2019 Results – Earnings Call Transcript – Seeking Alpha

Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q1 2019 Results – Earnings Call Transcript Seeking Alpha Vascular Biogenics Ltd. (NASDAQ:VBLT) Q1 2019 Earnings Conference Call May 15, 2019 8:30 AM…